AgencyIQ Blog » FDA Today
10 FOLLOWERS
Simplify the complex with customized blog posts on life sciences and chemical regulation from AgencyIQ. We bring daily updates and analysis on the things that matter to you - helping you get smarter about regulation about FDA on the horizon and your next course of action. AgencyIQ empowers you to use the most relevant regulatory updates and reinvest time in value-added strategy, communication,..
AgencyIQ Blog » FDA Today
2d ago
Draft guideline modernizes EMA recommendations on quality of inhaled, nasal products ..read more
AgencyIQ Blog » FDA Today
2d ago
FDA advisors endorse minimal residual disease (MRD) as accelerated approval endpoint for multiple myeloma ..read more
AgencyIQ Blog » FDA Today
2d ago
How a failed ALS drug provides a blueprint for the FDA to create a ‘Conditional Withdrawal’ pathway ..read more
AgencyIQ Blog » FDA Today
2d ago
To combat antimicrobial resistance, the FDA needs a reset ..read more
AgencyIQ Blog » FDA Today
2w ago
FDA’s oncology advisory committee to consider MRD as a multiple myeloma endpoint ..read more
AgencyIQ Blog » FDA Today
2w ago
FDA updates set the stage for broader use of harmonized standards for safety reporting ..read more
AgencyIQ Blog » FDA Today
2w ago
FDA flexes its new accelerated approval authorities, hoping to accelerate access to confirmatory data ..read more
AgencyIQ Blog » FDA Today
2w ago
EMA extends scientific advice pilot for high-risk medical devices ..read more
AgencyIQ Blog » FDA Today
2w ago
Accelerated Removal: FDA making use of new authority to withdraw ineffective drugs more quickly ..read more